Recently, a new study revealed that Cicr-DOCK1 interacts with miR-132-3p to inhibit its effect on USP11, thereby promoting the proliferation, invasion, and migration of CRC [32]. The gene discussed is DOCK1; the disease is colorectal carcinoma.